European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 2, 2006, Pages 418-422

  Coenen, Samuel ^a,b   Ferech, Matus ^a   Malhotra Kumar, Surbhi ^a   Hendrickx, Erik ^c   Suetens, Carl ^c   Goossens, Herman ^a,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ambulatory care; Antibiotic use; Drug consumption; Europe; Macrolides; Pharmacoepidemiology

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; FLURITHROMYCIN; JOSAMYCIN; LINCOSAMIDE; LINCOSAMIDE DERIVATIVE; LINDAMYCIN; LONG ACTING DRUG; MACROLIDE; MIDECAMYCIN; MIOKAMYCIN; OLEANDOMYCIN; PRISTINAMYCIN; QUINUPRISTIN; ROKITAMYCIN; ROXITHROMYCIN; SHORT ACTING DRUG; SPIRAMYCIN; STREPTOGRAMIN; TELITHROMYCIN; TROLEANDOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SURVEILLANCE PROGRAM; DRUG USE; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION PROCESSING; OUTPATIENT CARE; PRESCRIPTION; SEASONAL VARIATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EUROPE; HUMANS; LINCOSAMIDES; MACROLIDES; OUTPATIENTS; STREPTOGRAMINS;

EID: 33748063957     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl184     Document Type: Article

References (10)

1. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe. J Antimicrob Chemother 2006; 58: 401-7.
2. Vander Stichele R, Elseviers M, Ferech M et al. European surveillance of antimicrobial consumption (ESAC): Data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
3. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national data-base study. Lancet 2005; 365: 579-87.
4. Ferech M, Coenen S, Dvorakova K et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient penicillin use in Europe. J Antimicrob Chemother 2006; 58: 408-12.
5. Coenen S, Ferech M, Dvorakova K et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient cephalosporin use in Europe. J Antimicrob Chemother 2006; 58: 413-17.
6. Namour F, Wessels DH, Pascual MH et al. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses. Antimicrob Agents Chemother 2001; 45: 170-5.
7. Felmingham D, Reinert R, Hirakata YAR. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002; 50 Suppl S1: 25-37.
8. Beekmann S, Heilmann K, Richter S et al. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 2005; 25: 148-56.
9. Garcia-Rey C, Aguilar L, Baquero F et al. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 2002; 40: 159-64.
10. Kastner U, Guggenbichler J. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 2001; 29: 251-6.